Trinity Biotech plc (TRIB)

Market Cap	5.42M
Revenue (ttm)	61.56M
Net Income (ttm)	-31.79M
Shares Out	3.71M
EPS (ttm)	-9.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	224,305
Open	1.480
Previous Close	1.540
Day's Range	1.420 - 1.530
52-Week Range	0.480 - 3.440
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2025

About TRIB

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, v...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: NASDAQ
• Ticker Symbol: TRIB
• Website: https://www.trinitybiotech.com

Financial Performance

In 2024, Trinity Biotech's revenue was $61.56 million, an increase of 8.31% compared to the previous year's $56.83 million. Losses were -$31.79 million, 32.4% more than in 2023.